BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5778194)

  • 1. Cognitive disorder among the szhizophrenias. 3. Retardation.
    Foulds GA; Hope K; McPherson FM; Mayo PR
    Br J Psychiatry; 1969 Feb; 115(519):177-80. PubMed ID: 5778194
    [No Abstract]   [Full Text] [Related]  

  • 2. Psychoses in adult mental defectives. II. Schizophrenic and paranoid psychoses.
    Reid AH
    Br J Psychiatry; 1972 Feb; 120(555):213-8. PubMed ID: 4261387
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessing schizophrenia in adults with mental retardation. A comparative study.
    Meadows G; Turner T; Campbell L; Lewis SW; Reveley MA; Murray RM
    Br J Psychiatry; 1991 Jan; 158():103-5. PubMed ID: 2015430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schizophrenic response to affectivity in word definition.
    Chapman LJ; Chapman JP; Daut RL
    J Abnorm Psychol; 1974 Dec; 83(6):616-22. PubMed ID: 4217344
    [No Abstract]   [Full Text] [Related]  

  • 5. Cognitive disturbances in chronic schizophrenia: formal thought disorder and basic symptoms.
    Simhandl C; Dietzel M; Lesch OM; Musalek M; Strobl R
    Psychopathology; 1986; 19(4):206-12. PubMed ID: 2882543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paranoid and withdrawal symptoms in schizophrenia: relationship to reaction time.
    Goldberg SC; Schooler NR; Mattsson N
    Br J Psychiatry; 1968 Sep; 114(514):1161-5. PubMed ID: 5684665
    [No Abstract]   [Full Text] [Related]  

  • 7. Is cognitive insight relevant to functional capacity in schizophrenia?
    Benoit A; Bowie CR; Lepage M
    Schizophr Res; 2017 Jun; 184():150-151. PubMed ID: 28069313
    [No Abstract]   [Full Text] [Related]  

  • 8. Temporal lobe "spike focus" associated with confusion, complete amnesia and fugues in a paranoid schizophrenic.
    Zlotlow M
    Psychiatr Q; 1968; 42(4):738-48. PubMed ID: 5729555
    [No Abstract]   [Full Text] [Related]  

  • 9. Peripheral oxytocin and vasopressin are associated with clinical symptom severity and cognitive functioning in midlife women with chronic schizophrenia.
    Rubin LH; Wehring HJ; Demyanovich H; Sue Carter C; Pournajafi-Nazarloo H; Feldman SM; Earl AK; August S; Gold JM; Kelly DL
    Schizophr Res; 2018 May; 195():409-411. PubMed ID: 28965776
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessing metacognition in schizophrenia with the Metacognition Assessment Scale: associations with the Social Cognition and Object Relations Scale.
    Lysaker PH; Dimaggio G; Daroyanni P; Buck KD; LaRocco VA; Carcione A; Nicolò G
    Psychol Psychother; 2010 Sep; 83(Pt 3):303-15. PubMed ID: 20170602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitatively distinct factors contribute to elevated rates of paranoia in autism and schizophrenia.
    Pinkham AE; Sasson NJ; Beaton D; Abdi H; Kohler CG; Penn DL
    J Abnorm Psychol; 2012 Aug; 121(3):767-777. PubMed ID: 22686868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive function in schizoaffective disorder and clinical subtypes of schizophrenia.
    Goldstein G; Shemansky WJ; Allen DN
    Arch Clin Neuropsychol; 2005 Mar; 20(2):153-9. PubMed ID: 15708725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological characteristics of child and adolescent offspring of patients with schizophrenia or bipolar disorder.
    de la Serna E; Sugranyes G; Sanchez-Gistau V; Rodriguez-Toscano E; Baeza I; Vila M; Romero S; Sanchez-Gutierrez T; Penzol MJ; Moreno D; Castro-Fornieles J
    Schizophr Res; 2017 May; 183():110-115. PubMed ID: 27847227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired intellect and memory: a missing link between genetic risk and schizophrenia?
    Toulopoulou T; Goldberg TE; Mesa IR; Picchioni M; Rijsdijk F; Stahl D; Cherny SS; Sham P; Faraone SV; Tsuang M; Weinberger DR; Seidman LJ; Murray RM
    Arch Gen Psychiatry; 2010 Sep; 67(9):905-13. PubMed ID: 20819984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigation of Leonhard's classification of chronic schizophrenia.
    Basit A
    Psychiatr Q; 1971; 45(2):172-81. PubMed ID: 5147540
    [No Abstract]   [Full Text] [Related]  

  • 16. A pilot study to measure cognitive impairment in patients with severe schizophrenia with the Montreal Cognitive Assessment (MoCA).
    Wu C; Dagg P; Molgat C
    Schizophr Res; 2014 Sep; 158(1-3):151-5. PubMed ID: 25092174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained and selective attention in schizophrenia.
    Green MF; Nuechterlein KH; Gaier DJ
    Prog Exp Pers Psychopathol Res; 1992; 15():290-313. PubMed ID: 1343109
    [No Abstract]   [Full Text] [Related]  

  • 18. Cognitive deficits and its relation with psychopathology and global functioning in first episode schizophrenia.
    Hegde S; Thirthalli J; Rao SL; Raguram A; Philip M; Gangadhar BN
    Asian J Psychiatr; 2013 Dec; 6(6):537-43. PubMed ID: 24309868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reaction time and attention in schizophrenia: a critical evaluation of the data and theories.
    Nuechterlein KH
    Schizophr Bull; 1977; 3(3):373-428. PubMed ID: 335494
    [No Abstract]   [Full Text] [Related]  

  • 20. Predicting quality of life impairment in chronic schizophrenia from cognitive variables.
    Ritsner MS
    Qual Life Res; 2007 Aug; 16(6):929-37. PubMed ID: 17404898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.